Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     

Australia's Leading Ophthalmic Magazine Since 1975

     Free Sign Up     
News

Glaukos completes acquisition of DOSE Medical

09/07/2019By Callum Glennen
Share:
Glaukos has completed its acquisition of DOSE Medical Corporation, a developer of micro-invasive delivery platforms, in a deal worth US$2.5 million (AU$3.6 m).

The agreement, which was initially announced in June, will see DOSE’s ongoing development of bioerodible and sustained-release drug delivery platforms rolled into Glaukos’ portfolio. DOSE reportedly has multiple projects currently underway, primarily focussed on the areas of age-related macular degeneration (AMD) and diabetic macular edema.

Thomas Burns, Glaukos’ president and chief executive officer
Thomas Burns, Glaukos’ president and chief executive officer
“We plan to build upon the promising work DOSE Medical has already done, while leveraging our unique expertise in disruptive, micro-scale innovation”
Thomas Burns, Glaukos

At the time the deal was announced, Mr Thomas Burns, president and CEO of Glaukos, said it would build on his company’s legacy as an ophthalmic pioneer.

“With this acquisition, Glaukos will establish a new R&D retinal program that complements our growing glaucoma franchise and pipeline. We plan to build upon the promising work DOSE Medical has already done, while leveraging our unique expertise in disruptive, micro-scale innovation to advance exciting new treatment options for AMD and other retinal diseases,” Burns said.

The transaction means that DOSE is will now once again be a wholly owned subsidiary of the company. In 2010 Glaukos spun DOSE out as a stand-alone entity, and in 2015 re-acquired the iDose line of products back from it for US$26 million (AU$37 m).

In 2017, Glaukos acquired DOSE’s intraocular pressure sensor system for US$5.5 million (AU$7.9 m), with an additional US$9.5 million (AU$13.6 m) contingent on whether several development milestones were reached.

 

More reading:

Santen and Glaukos enter MIGS distribution agreement
Designs for Vision
advertisement





Display 1
advertisement
Editor's Suggestion
Hot Stories

Face A Face
advertisement


OR
 

Subscribe for Insight in your Inbox

Get Insight with the latest in industry news, trends, new products, services and equipment!